These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1144074)

  • 1. [Combination therapy in Hodgkin's disease consisting of vincaleukoblastine, cyclophosphamide and natulan].
    Zelechowska JA; Madej C; Leszczyk CZ; Dabrowska W; Pieńkowska F
    Nowotwory; 1975; 25(2):157-66. PubMed ID: 1144074
    [No Abstract]   [Full Text] [Related]  

  • 2. [Vinblastine + procarbazine + cyclophosphamide association in the treatment of Hodgkin's disease (author's transl)].
    Chauvergne J; Hoerni B; Hoerni-Simon G; Durand M; Lagarde C
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1973 Nov; 80(2):179-88. PubMed ID: 4271955
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation of vincaleukoblastine treatment of patients with advanced Hodgkin's disease according to the records of the Institute of Oncology in Warsaw].
    Zelechowska JA
    Nowotwory; 1972; 22(2):131-7. PubMed ID: 5038534
    [No Abstract]   [Full Text] [Related]  

  • 4. BCNU, velban, cyclophosphamide, procarbazine, and prednisone (BVCPP) in advanced Hodgkin's disease.
    Durant JR; Gams RA; Velez-Garcia E; Bartolucci A; Wirtschafter D; Dorfman R
    Cancer; 1978 Nov; 42(5):2101-10. PubMed ID: 719600
    [No Abstract]   [Full Text] [Related]  

  • 5. Combinaed chemotherapy with cyclophosphamide, vinblastine, procarbazine, and prednisone (CVPP) for patients with advanced Hodgkin's disease. An alternative program to MOPP.
    Bloomfield CD; Weiss RB; Fortuny I; Vosika G; Kennedy BJ
    Cancer; 1976 Jul; 38(1):42-8. PubMed ID: 947533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Zitostop in cyclical treatment of malignant lymphoma in combination with vinblastine, natulan and prednisone].
    Polubiec A
    Wiad Lek; 1976 Mar; 29(6):477-81. PubMed ID: 178108
    [No Abstract]   [Full Text] [Related]  

  • 7. Updated Hodgkins' disease. C. Advanced disease and special problems. Advances in chemotherapy.
    Frei E; Luce JK
    JAMA; 1973 Jan; 223(2):166-8. PubMed ID: 4739456
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term follow-up of two chemotherapy protocols in Hodgkin's disease.
    Pavlovsky S; Morgenfeld M; Somoza N; Magnasco J; Sackmann Muriel F; Cavagnaro F; Suárez A; Barros CA; Saslavsky J; Garay G; Palau M; Besuschio SC
    Medicina (B Aires); 1981; 41 Suppl():15-21. PubMed ID: 6896551
    [No Abstract]   [Full Text] [Related]  

  • 9. Cyclophosphamide, vinblastine, procarbazine and prednisone with CCNU and vinblastine maintenance for advanced Hodgkin's disease.
    Diggs CH; Wiernik PH; Levi JA; Kvols LK
    Cancer; 1977 May; 39(5):1949-54. PubMed ID: 870162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined drug treatment of Hodgkin's disease: remission induction, remission duration, and survival; an appraisal.
    DeVita VT
    Natl Cancer Inst Monogr; 1973 May; 36():373-9. PubMed ID: 4744596
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of different drugs and combinations in the treatment of Hodgkin's disease.
    Fairley GH
    Ser Haematol; 1973; 6(2):196-201. PubMed ID: 4784374
    [No Abstract]   [Full Text] [Related]  

  • 12. [Early results of combined treatment in Hodgkin's disease with nitrogen mustard, vincristine, Natulan and prednisone (MOPP treatment)].
    Zelechowska JA; Madej G; Piemkowska F
    Nowotwory; 1976; 26(3):163-70. PubMed ID: 980801
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment maintaining complete remission in Hodgkin's disease].
    Armata J
    Pol Tyg Lek; 1981 Feb; 36(8):301-4. PubMed ID: 7022410
    [No Abstract]   [Full Text] [Related]  

  • 14. Eastern cooperative oncology group studies.
    Lenhard RE
    Arch Intern Med; 1973 Mar; 131(3):418-20. PubMed ID: 4688039
    [No Abstract]   [Full Text] [Related]  

  • 15. Combined chemotherapy cyclophosphamide, vinblastine, procarbazine and prednisone (CVPP) vs. CVPP plus CCNU (CCVPP) in Hodgin's disease.
    Morgenfeld M; Somoza N; Magnasco J; Pavlovsky S; de Bonesana AC; Bezares R; Suárez A; Pileggi J; Lein JM; Macchi A; Calabria SI; Garay GE; de Sica SC; Besuschio S
    Cancer; 1979 May; 43(5):1579-86. PubMed ID: 376095
    [No Abstract]   [Full Text] [Related]  

  • 16. [Diagnosis and therapy of Hodgkin's disease in childhood].
    Kühner U; Bleher EA; Grétillat P; Gasser M; Pedrinis E; Tonella A; Wagner HP
    Monatsschr Kinderheilkd (1902); 1976 May; 124(5):408-10. PubMed ID: 934132
    [No Abstract]   [Full Text] [Related]  

  • 17. Combination chemotherapy of advanced Hodgkin's disease. A review.
    Goldsmith MA; Carter SK
    Cancer; 1974 Jan; 33(1):1-8. PubMed ID: 4129559
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of Hodgkin's disease. Experience of the Hôpital Saint-Louis].
    Boiron M; Teillet F; Weisgerber C; Dana M; Jacquillat C; Bernard J
    Rev Prat; 1974 Oct; 24(45):3971-8. PubMed ID: 4445767
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term survival of patients with Hodgkin's disease. Treatment with cyclophosphamide, vinblastine, procarbazine, and prednisone.
    Gibbs GE; Peterson BA; Kennedy BJ; Vosika G; Bloomfield CD
    Arch Intern Med; 1981 Jun; 141(7):897-900. PubMed ID: 7235809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined cyclophosphamide vincristine, procarbazine, and prednisone (COPP) therapy of malignant lymphoma. Evaluation of 190 patients.
    Morgenfeld MC; Pavlovsky A; Suarez A; Somoza N; Pavlovsky S; Palau M; Barros CA
    Cancer; 1975 Oct; 36(4):1241-9. PubMed ID: 1100220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.